SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc. is experiencing heavy volatility as investors weigh strong quarterly revenue growth and improved profitability against concerns regarding search-driven traffic and user discovery. The community is sharply divided, with bulls pointing to the company's strong fundamentals and cash flow as a buying opportunity, while bears remain focused on moderation policies, AI-related search risks, and concerns over unsustainable valuations.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors digest the recent arrival of Siemens turbines for its Project Matador campus alongside a significant convertible note offering intended to fund upcoming strategic milestones. The community is sharply divided, with bulls pointing to the potential for a transformative anchor tenant deal and performance incentives for management, while bears emphasize the lack of revenue and concerns over continued dilution.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors debate whether the stock is a deep-value turnaround opportunity or a permanent laggard following its decision to restructure its digital distribution model in China. Community discussion is sharply divided between bulls accumulating shares on the belief that brand dominance will return and bears focusing on slowing revenue, competition from emerging athletic brands, and the stock's persistent inability to sustain price momentum.

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

Bausch Health is trending as investor interest surges following strong quarterly earnings, raised full-year guidance, and significant debt reduction efforts. Despite long-term challenges with leverage and patent exclusivity, the community is actively debating the company's valuation, potential assets divestment, and the impact of the Larsucosterol trial.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is seeing intense debate as community members weigh its recent performance against broader tech market trends, with many debating Cathie Wood's high-conviction buying strategies in speculative tech and crypto-related assets. Discussions are primarily fueled by institutional outflow data and retail frustration over the fund's long-term underperformance compared to traditional index benchmarks.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is attracting significant investor attention following a legal challenge against Eli Lilly over allegedly misleading advertising, while community sentiment remains buoyed by the EU approval of its oral Wegovy pill. Market participants are actively comparing the prescription momentum of Novo's oral therapies against its main competitor as they position themselves ahead of the upcoming earnings report.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is currently a key focus for market participants following a strong earnings report that showcased robust revenue growth and a record-high contract backlog. Investors are actively discussing the company's critical role in replenishing U.S. and allied defense inventories amid ongoing global geopolitical tensions and elevated demand for missile defense systems.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. is currently facing significant technical pressure with community members debating whether the stock's recent downtrend will lead to a deeper correction or provide a buying opportunity ahead of upcoming earnings. Investors are closely monitoring rising bond yields, geopolitical instability, and potential volatility in the AI sector as key factors that could dictate whether the stock tests lower support levels or stages a breakout.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as investors weigh the stock's massive short interest and potential for a sharp rebound ahead of upcoming earnings. Community sentiment is deeply polarized, with bulls viewing the current price as a generational buying opportunity based on strong brand loyalty, while bears remain focused on margin pressures and increased market competition.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending as shareholders express deep frustration over the company's communication silence and share price volatility, while debates intensify regarding whether the strategic focus on Matrix-M licensing and partnership potential outweighs ongoing management skepticism. Community discussion centers on upcoming earnings expectations, the status of the COVID-19-Influenza Combination (CIC) pipeline, and the impact of institutional positioning on the stock's performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ExxonMobil and Chevron reported sharply higher Q2 profits as rising oil prices, fueled by supply disruptions from the Iran war, lifted earnings across both production and refining operations. Chevron delivered stronger-than-expected results, posting adjusted EPS of $6.06 versus $5.56 expected and revenue of $70 billion, above the $62 billion consensus. Exxon generated revenue of $116 billion, well above expectations of $97.8 billion, but adjusted EPS of $3.52 missed estimates by 8 cents due to weaker-than-expected refining performance amid extreme market volatility. 
Chevron CEO Mike Wirth warned that global energy markets are &quot;running out of time&quot; as the conflict expands beyond the Strait of Hormuz into the Red Sea, threatening additional supply disruptions while global oil inventories continue to decline. Exxon CEO Darren Woods said unpredictable crude and refined product pricing made forecasting refining margins particularly difficult during the quarter. 
 $CVX $XOM

StockTwits Web

Chevron Corp.

Exxon Mobil Corp

ExxonMobil and Chevron reported sharply higher Q2 profits as rising oil prices, fueled by supply disruptions from the Iran war, lifted earnings across both production and refining operations. Chevron delivered stronger-than-expected results, posting adjusted EPS of $6.06 versus $5.56 expected and revenue of $70 billion, above the $62 billion consensus. Exxon generated revenue of $116 billion, well above expectations of $97.8 billion, but adjusted EPS of $3.52 missed estimates by 8 cents due to weaker-than-expected refining performance amid extreme market volatility. 
Chevron CEO Mike Wirth warned that global energy markets are "running out of time" as the conflict expands beyond the Strait of Hormuz into the Red Sea, threatening additional supply disruptions while global oil inventories continue to decline. Exxon CEO Darren Woods said unpredictable crude and refined product pricing made forecasting refining margins particularly difficult during the quarter. 
 